68 related articles for article (PubMed ID: 9925769)
21. A material decoy of biological media based on chitosan physical hydrogels: application to cartilage tissue engineering.
Montembault A; Tahiri K; Korwin-Zmijowska C; Chevalier X; Corvol MT; Domard A
Biochimie; 2006 May; 88(5):551-64. PubMed ID: 16626850
[TBL] [Abstract][Full Text] [Related]
22. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.
Guerassimov A; Zhang Y; Banerjee S; Cartman A; Leroux JY; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
Arthritis Rheum; 1998 Jun; 41(6):1019-25. PubMed ID: 9627011
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture.
Mandl EW; Jahr H; Koevoet JL; van Leeuwen JP; Weinans H; Verhaar JA; van Osch GJ
Matrix Biol; 2004 Jul; 23(4):231-41. PubMed ID: 15296937
[TBL] [Abstract][Full Text] [Related]
24. Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype.
Kokenyesi R; Tan L; Robbins JR; Goldring MB
Arch Biochem Biophys; 2000 Nov; 383(1):79-90. PubMed ID: 11097179
[TBL] [Abstract][Full Text] [Related]
25. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7.
Hidaka C; Quitoriano M; Warren RF; Crystal RG
J Orthop Res; 2001 Sep; 19(5):751-8. PubMed ID: 11562118
[TBL] [Abstract][Full Text] [Related]
26. Mechanoregulation of human articular chondrocyte aggrecan and type II collagen expression by intermittent hydrostatic pressure in vitro.
Ikenoue T; Trindade MC; Lee MS; Lin EY; Schurman DJ; Goodman SB; Smith RL
J Orthop Res; 2003 Jan; 21(1):110-6. PubMed ID: 12507587
[TBL] [Abstract][Full Text] [Related]
27. Control of human articular chondrocyte differentiation by reduced oxygen tension.
Murphy CL; Polak JM
J Cell Physiol; 2004 Jun; 199(3):451-9. PubMed ID: 15095292
[TBL] [Abstract][Full Text] [Related]
28. Joint inflammation and chondrocyte death become independent of Fcgamma receptor type III by local overexpression of interferon-gamma during immune complex-mediated arthritis.
Nabbe KC; Boross P; Holthuysen AE; Sloëtjes AW; Kolls JK; Verbeek S; van Lent PL; van Den Berg WB
Arthritis Rheum; 2005 Mar; 52(3):967-74. PubMed ID: 15751061
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of chondrocyte aggrecan and type-II collagen gene expression correlates with increases in static compression magnitude and duration.
Ragan PM; Badger AM; Cook M; Chin VI; Gowen M; Grodzinsky AJ; Lark MW
J Orthop Res; 1999 Nov; 17(6):836-42. PubMed ID: 10632450
[TBL] [Abstract][Full Text] [Related]
30. Enhanced proliferation and differentiation of human articular chondrocytes when seeded at low cell densities in alginate in vitro.
Gagne TA; Chappell-Afonso K; Johnson JL; McPherson JM; Oldham CA; Tubo RA; Vaccaro C; Vasios GW
J Orthop Res; 2000 Nov; 18(6):882-90. PubMed ID: 11192247
[TBL] [Abstract][Full Text] [Related]
31. G3 domains of aggrecan and PG-M/versican form intermolecular disulfide bonds that stabilize cell-matrix interaction.
Chen L; Yang BL; Wu Y; Yee A; Yang BB
Biochemistry; 2003 Jul; 42(27):8332-41. PubMed ID: 12846582
[TBL] [Abstract][Full Text] [Related]
32. Growth and integration of neocartilage with native cartilage in vitro.
Zhang Z; McCaffery JM; Spencer RG; Francomano CA
J Orthop Res; 2005 Mar; 23(2):433-9. PubMed ID: 15734259
[TBL] [Abstract][Full Text] [Related]
33. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
34. Aggrecan and link protein affect cell adhesion to culture plates and to type II collagen.
Yang BB; Zhang Y; Cao L; Yang BL
Matrix Biol; 1998 Mar; 16(9):541-61. PubMed ID: 9569123
[TBL] [Abstract][Full Text] [Related]
35. Adhesion characteristics of chondrocytes cultured separately and in co-cultures with synovial fibroblasts.
Nevo Z; Silver J; Chorev Y; Riklis I; Robinson D; Yosipovitch Z
Cell Biol Int; 1993 Mar; 17(3):255-73. PubMed ID: 7685648
[TBL] [Abstract][Full Text] [Related]
36. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants.
Tiku ML; Gupta S; Deshmukh DR
Free Radic Res; 1999 May; 30(5):395-405. PubMed ID: 10342332
[TBL] [Abstract][Full Text] [Related]
37. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells.
Cattaruzza S; Schiappacassi M; Kimata K; Colombatti A; Perris R
FASEB J; 2004 Apr; 18(6):779-81. PubMed ID: 14977887
[TBL] [Abstract][Full Text] [Related]
38. A remote upstream element regulates tissue-specific expression of the rat aggrecan gene.
Doege K; Hall LB; McKinnon W; Chen L; Stephens DT; Garrison K
J Biol Chem; 2002 Apr; 277(16):13989-97. PubMed ID: 11834732
[TBL] [Abstract][Full Text] [Related]
39. Internalization of aggrecan G1 domain neoepitope ITEGE in chondrocytes requires CD44.
Ariyoshi W; Knudson CB; Luo N; Fosang AJ; Knudson W
J Biol Chem; 2010 Nov; 285(46):36216-24. PubMed ID: 20843796
[TBL] [Abstract][Full Text] [Related]
40. Degradation of aggrecan precursors within a specialized subcompartment of the chicken chondrocyte endoplasmic reticulum.
Alonso M; Hidalgo J; Hendricks L; Velasco A
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):487-95. PubMed ID: 8687392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
